Malignant Digestive System Neoplasm Clinical Trial
Official title:
Can Narrative Medicine Methods Improve Well-Being in Patients With GI Malignancies
This clinical trial assesses whether narrative medicine methods may improve the sense of well-being among gastrointestinal (GI) (digestive system) cancer patients. Narrative medicine is a clinical approach where providers can use a patient's own narrative (perspective) of their illness to promote healing and resilience. By applying narrative medicine's main tool, close reading, to clinical practice, clinicians learn to listen and attend to patients more deeply. This allows for freer communication and the creation of a healthcare encounter that centers on the psychological and emotional well being of the patient in addition to their medical conditions. Narrative medicine can include close reading, creative or reflective writing, and discussion. These methods may help patients with GI cancer to reflect on their life stories, both inside and outside of their illness experience, and help them gather skills to optimize their well-being.
PRIMARY OBJECTIVES: I. To assess the feasibility of implementing narrative medicine tools in serial workshops with patients with malignancy. II. To determine if narrative medicine interventions improve markers and expressions of well-being. DESCRIPTIVE OBJECTIVES: I. To estimate changes in markers and expressions of well-being after 3 sessions of narrative medicine intervention. II. To determine, through qualitative methods, if patients find benefit from the intervention regarding their well-being. III. To decide whether to expand these kinds of interventions to a larger study with control group. OUTLINE: Patients participate in narrative medicine sessions over 60 minutes once every 2 weeks (Q2W) for 3 sessions. After completion of study intervention, patients are followed up at 1 and 3 months. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05179486 -
Molecular Epidemiology of Biliary Tree Cancers
|
||
| Active, not recruiting |
NCT04986566 -
Perioperative Telemonitoring to Optimize Cancer Care and Outcomes
|
N/A | |
| Active, not recruiting |
NCT03267524 -
Walking for Recovery From Surgery in Improving Quality of Life in Older Adults With Lung or Gastrointestinal Cancer and Their Family Caregivers
|
N/A | |
| Recruiting |
NCT05107219 -
GCC Agonist Signal in the Small Intestine
|
Phase 1 | |
| Suspended |
NCT04111172 -
A Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal Adenocarcinoma
|
Phase 2 | |
| Recruiting |
NCT00991094 -
Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy
|
||
| Recruiting |
NCT03800693 -
2 Versus 6 Hour Oxaliplatin Infusions in Patients With Gastrointestinal Cancers
|
Phase 2 | |
| Active, not recruiting |
NCT04505553 -
Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT04501913 -
Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes
|
||
| Recruiting |
NCT05018208 -
Remote Monitoring in Cancer Care: A Platform Study
|
||
| Withdrawn |
NCT03563352 -
Nutritional Preferences and Product Accessibility in Oral Nutritional Supplements in Participants With Breast, Colorectal, Upper Gastrointestinal, or Prostate Cancer
|
||
| Completed |
NCT02192333 -
Survivorship Care in Reducing Symptoms in Young Adult Cancer Survivors
|
N/A | |
| Completed |
NCT02713269 -
Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal Cord
|
Phase 2 | |
| Completed |
NCT02319018 -
Alisertib and Combination Chemotherapy in Treating Patients With Gastrointestinal Tumors
|
Phase 1 | |
| Active, not recruiting |
NCT02221700 -
Massage Therapy in Reducing Chemotherapy-Induced Peripheral Neuropathy in Patients With Gastrointestinal or Breast Malignancies
|
N/A | |
| Recruiting |
NCT04629677 -
Evaluation of Portal Vein Stenting in Patients With Portal Vein Stenosis and Gastrointestinal Cancers
|
||
| Terminated |
NCT02550119 -
Dolasetron Mesylate and Dexamethasone With or Without Aprepitant in Preventing Nausea and Vomiting in Patients Undergoing Oxaliplatin-Containing Chemotherapy for Gastrointestinal Malignancy
|
N/A |